A new study has found that a mutated gene, called IDH1, could be the key to the development of some types of glioma brain tumour.
The latest study, by US firm Agios Pharmaceuticals, has revealed that the mutation leads to hugely increased levels of a chemical in the brain, which seems to feed the cancer.
About Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.
The research also raises hopes that blocking production of the chemical might prevent the cancer getting worse.
People with particular brain tumours, such as lower-grade gliomas, often carry a mutated version of a gene controlling the production of IDH1 enzyme.
Head Injury | Brain Injury Overview Types Causes Symptoms Diagnosis Treatment
Head injury or traumatic brain injury is a leading cause of disability among children and young adults that leads to varying degrees of physical and mental stability. Fortunately, it is also one of the preventable brain disorder.
Head injury or traumatic brain injury is a leading cause of disability among children and young adults that leads to varying degrees of physical and mental stability. Fortunately, it is also one of the preventable brain disorder.
Researchers found malignant glioma samples with IDH1 mutations had 100 times more 2HG than similar samples from patients without the mutation.
Advertisement
Brilliant Human Brain
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.
"This will be important for prognosis as patients with IDH1 mutations live longer than patients with gliomas characterised by other mutations," the BBC quoted the researchers as saying.
Advertisement
Brain Depression
Interactive section of Medindia provides information about chemistry of Brain depression
Interactive section of Medindia provides information about chemistry of Brain depression
"Inhibition of 2HG production by mutant IDH1 might slow or halt conversion of lower-grade glioma into lethal secondary glioblastoma, changing the course of the disease," they added.
Professor Lew Cantley, a cancer expert at the Beth Israel Deaconess Medical Center, who founded Agios, said it had previously been thought that IDH1 played no role in cancer.
The researchers used techniques from an emerging area of research called cancer metabolism, which focuses on studying changes in metabolic activity in cancer cells.
"What was previously considered an inactive enzyme is in reality an active oncogene and a potential therapeutic target," he said.
The study has been published in Nature.
Source-ANI
RAS
